Management of Thyrotoxicosis Induced by PD1 or PD-L1 Blockade

Mostrar otras versiones (1)

CONTEXT: Thyrotoxicosis is a common immune-related adverse event in patients treated with programmed cell death protein-1 (PD1) or programmed cell death protein ligand-1 (PD-L1) blockade. A detailed endocrinological assessment, including thyroid ultrasound and scintigraphy, is lacking, as are data o...

Descripción completa

Detalles Bibliográficos
Autores principales: Brancatella, Alessandro, Lupi, Isabella, Montanelli, Lucia, Ricci, Debora, Viola, Nicola, Sgrò, Daniele, Antonangeli, Lucia, Sardella, Chiara, Brogioni, Sandra, Piaggi, Paolo, Molinaro, Eleonora, Bianchi, Francesca, Aragona, Michele, Antonuzzo, Andrea, Sbrana, Andrea, Lucchesi, Maurizio, Chella, Antonio, Falcone, Alfredo, del Prato, Stefano, Elisei, Rossella, Marcocci, Claudio, Caturegli, Patrizio, Santini, Ferruccio, Latrofa, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317632/
https://www.ncbi.nlm.nih.gov/pubmed/34337277
http://dx.doi.org/10.1210/jendso/bvab093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317632/
https://www.ncbi.nlm.nih.gov/pubmed/34337277
http://dx.doi.org/10.1210/jendso/bvab093

Ejemplares similares